IVUS Saves Lives: From Data to Practice
Published: 15 April 2024
-
Views:
368
-
Likes:
7
-
Views:
368
-
Likes:
7
-
10m 16s
-
16m 36s
Overview
This Breakout, held at Transcatheter Interventions Online 2024, explored the pivotal role of education in enhancing outcomes for patients with LM disease. The faculty explore the transformative impact of imaging on LM management and patient outcomes, and consider a systematic algorithm designed to optimise IVUS utilisation in LM treatment, offering step-by-step guidance for improved clinical decision-making.
Engage in this enlightening session as the faculty unravel key strategies for advancing care in LM disease management.
Learning Objectives
- To understand the critical role that education plays in improving the outcomes for patients with LM disease
- To understand the critical role that education plays in improving the outcomes for patients with LM disease
- How a step-by-step algorithm can help to optimise the use of IVUS in LM treatment
Target Audience
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Part 1
Welcome
Part 2
Modern PCI Approach to Left Main Treatment
Part 3
Modern PCI Approach to Left Main Treatment
Part 4
Modern PCI Approach to Left Main Treatment
Faculty Biographies
James Spratt
Professor of Interventional Cardiology
Prof James Spratt is a Professor of Interventional cardiology. A high-volume Interventional Cardiologist with an international reputation in complex PCI, with a sub-speciality interest in intravascular imaging and CTO. Widely published within this area and has performed live case demonstrations globally. He is interested in medical education and is the Founder of Optima Education. Prof James Spratt is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).
Francis Richard Joshi
Dr Francis Richard Joshi is a Cardiologist at the Golden Jubilee National Hospital, Agamemnon St, Clydebank in Glasgow, UK.
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Mirvat Alasnag
Director of Catheterization Laboratory
Dr Mirvat Alasnag is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3), joining the board in October 2020 and is also on the editorial board for US Cardiology Review (USC).
Dr Mirvat Alasnag is the Director of the Catheterization Laboratory at the King Fahad Armed Forces Hospital in Jeddah, Saudi Arabia. She was the first female interventional cardiologist in the Gulf region and has since represented women on multiple medical committees, including the Saudi Arabian Cardiac Interventional Society Board & the EAPCI Women’s Steering Committee. She is the current ACCWIC International Working Group Chair and an SCAI WIN member.
Dr Alasnag trained in Clinical Cardiology and Interventional Cardiology at Loma Linda University Medical Center (Loma Linda, California) and Harper University Hospital, Detroit Medical Center (Detroit, Michigan), respectively. Since her graduation in 2009 to date, she has been…